Results 191 to 200 of about 23,896 (206)

The potential of biologics for the treatment of asthma

Nature Reviews Drug Discovery, 2012
Girolamo Pelaia, Alessandro Vatrella, Rosario Maselli   +2 more
exaly  

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

New England Journal of Medicine, 2018
Ian D Pavord, Jorge F Maspero, Sally E Wenzel   +2 more
exaly  

KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma

New England Journal of Medicine, 2017
Katherine Niederer Cahill, Jing Cui, Juying Lai   +2 more
exaly  

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Lancet, The, 2012
Ian D Pavord, Peter Howarth, Oliver N Keene   +2 more
exaly  

Immunophenotype of airway eosinophils in severe eosinophilic asthma

Airway cell biology and immunopathology
Thomas Stoup, Arnaud Dendooven, Emilie Delaunay, Edouard Cuvillon, Stephane Esnault, Louison Jan, Xing Li, Victor Margelidon-Cozzolino, Jacques Trauet, Thibault Vanderhaegen, Guillaume Lefevre, Geoffrey Mortuaire, Cécile Chenivesse   +12 more
openaire   +1 more source

A Comparison of Inhaled Fluticasone and Oral Prednisone for Children with Severe Acute Asthma

New England Journal of Medicine, 2000
Suzanne Schuh, Annie Dupuis
exaly  

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

New England Journal of Medicine, 2018
Klaus F Rabe, Parameswaran Nair, Guy G Brusselle   +2 more
exaly  

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Lancet, The, 2016
Eugene R Bleecker, J Mark Fitzgerald, Alberto A Papi   +2 more
exaly  

Management of severe asthma in children

Lancet, The, 2010
Andrew Bush, Sejal Saglani
exaly  

Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma

Lancet, The, 1998
A Barry Kay
exaly